Company intelligence / Profile preview
Grandsoul Research Institute for Immunology
Uda, Nara, Japangrandsoul-immuno.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
The company specializes in cancer immunotherapy research, including neoantigen identification for peptide and dendritic cell vaccines, and has published peer-reviewed studies utilizing human PBMCs and proprietary cryopreservation reagents (CELLBANKER)
- Therapeutic areas
- Oncology
- Modalities
- Cell therapyGene therapyVaccineDendritic cell therapyPeptides
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Clinics such as Clinic Grandsoul, NaraNara Medical University (research publications)
Beyond the preview
Go deeper on Grandsoul Research Institute for Immunology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Grandsoul Research Institute for Immunology.